Evidence map›Paper›PMID 40433665›Full record

ArticleFrontiers in cellular and infection microbiology2025

Overexpression in

Yunuen Avalos-Padilla, Inés Bouzón-Arnáiz, Miriam Ramírez, Claudia Camarero-Hoyos, Marc Orozco-Quer, Elsa M Arce, Diego Muñoz-Torrero, Xavier Fernàndez-Busquets

Abstract read
In one paragraph

Article in Frontiers in cellular and infection microbiology, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.

0numbers the graph read from it
0cells of the map it votes in
1citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

1 citing paper in PubMed.

  1. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

8 authors.

Yunuen Avalos-PadillaBarcelona Institute for Global Health (ISGlobal), Hospital Clínic-Universitat de Barcelona, Barcelona, Spain.
Inés Bouzón-ArnáizBarcelona Institute for Global Health (ISGlobal), Hospital Clínic-Universitat de Barcelona, Barcelona, Spain.
Miriam RamírezBarcelona Institute for Global Health (ISGlobal), Hospital Clínic-Universitat de Barcelona, Barcelona, Spain.
Claudia Camarero-HoyosBarcelona Institute for Global Health (ISGlobal), Hospital Clínic-Universitat de Barcelona, Barcelona, Spain.
Marc Orozco-QuerNanomalaria Group, Institute for Bioengineering of Catalonia (IBEC), The Barcelona Institute of Science and Technology, Barcelona, Spain.
Elsa M ArceLaboratory of Medicinal Chemistry, Faculty of Pharmacy and Food Sciences, University of Barcelona, Barcelona, Spain.
Diego Muñoz-TorreroLaboratory of Medicinal Chemistry, Faculty of Pharmacy and Food Sciences, University of Barcelona, Barcelona, Spain.
Xavier Fernàndez-BusquetsBarcelona Institute for Global Health (ISGlobal), Hospital Clínic-Universitat de Barcelona, Barcelona, Spain.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

The proteome of

Indexed as

Intrinsically Disordered ProteinsPlasmodium falciparumProteostasisProtozoan ProteinsUbiquitin-Protein LigasesAntimalarialsArtemisininsHumansProteasome Endopeptidase ComplexProtein AggregatesAntimalarialsArtemisininsartenimolIntrinsically Disordered ProteinsProteasome Endopeptidase ComplexProtein AggregatesProtozoan ProteinsUbiquitin-Protein LigasesE3 ubiquitin ligasesnew antimalarial therapiesPlasmodium falciparumprotein aggregationproteostasis disruption

Identifiers

PMID40433665
PMCPMC12106546

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.